Ilika (IKA) CMD 2025 Presentation summary

Management and team experience

• Leadership team brings expertise from sectors including energy, technology, and finance, with backgrounds at companies such as Rolls Royce, Meggitt, Arm, and Avantium.

• CEO has led the company since 2004, overseeing VC funding rounds and IPO.

• CFO appointed in 2023, with prior experience in finance roles at Sunseeker, B&Q, and Kerry Foods.

• Board includes non-executive directors with deep experience in investment banking, corporate finance, and technology.

• Senior management includes experts in product development, sales, and marketing, with strong academic and industry credentials.

Business model and strategy

• Operates an asset-light, licensing-based business model, leveraging manufacturing partnerships for scale.

• Generates revenue through licensing, royalties, engineering fees, and grant support.

• Manufacturing partners handle production and sales to OEMs, while company focuses on IP and development.

• Capital-efficient approach supports rapid industry adoption and scalability.

Product portfolio and technology

• Two main product lines: Stereax (miniature batteries for medical/IoT) and Goliath (large-format batteries for automotive and appliances).

• Stereax licensed to Cirtec Medical, targeting medical devices and industrial IoT, with manufacturing partnership operational.

• Goliath targets automotive sector, with MVP due in 2026 and evaluation agreements with 21 OEMs/Tier 1 suppliers.

• 21 years of R&D, 62 patents, and £51m invested to date.